Kenvue
Update in progressKVUE (NYSE)
- Company RatingNeutralCompany RatingCombines sentiment and sustainability signals into an overall assessment of the company.Great · Good · Neutral · At Risk · Poor
- SectorConsumer Defensive
- IndustryHousehold & Personal Products
Kenvue Inc. is a consumer health company with operations across the Americas, Europe, the Middle East, Africa, and the Asia-Pacific region. It has three segments: Self Care, Skin Health and Beauty, and Essential Health. It offers OTC medicines for cough, cold, allergy, pain, digestive health, smoking cessation, and eye care, plus personal care, vitamins, and digital health services. Brands include Benadryl, Tylenol, Motrin, Aveeno, Neutrogena, Band-AID, Listerine, Benylin, Sudafed, Visine, and many others. Based in Summit, New Jersey, and incorporated in 2022.
Company score
- Sentiment
- 0.37
- SentimentMeasures the overall tone of recent coverage and discussion about the company.−10 negative · 0 neutral · +10 positive
- Environment
- 0.18
- EnvironmentAssesses the company’s environmental impact, risks, and sustainability practices.−10 negative · 0 neutral · +10 positive
- Social
- -0.31
- Governance
- -0.28
- GovernanceAssesses leadership, accountability, transparency, and business ethics.−10 negative · 0 neutral · +10 positive
- Sustainability
- -0.09
- SustainabilityCombines environmental, social, and governance signals into an overall sustainability score.−10 negative · 0 neutral · +10 positive
- Impact Score
- 0.14
- Impact ScoreCombines sentiment and sustainability performance into an assessment of the company’s overall impact.−10 negative · 0 neutral · +10 positive
Company
- MarketNYSE (NYQ)
- LocationUnited States
- CEOMr. Kirk L. Perry
- Founded2022
- Employees21,780
- Websitewww.kenvue.com
Identifiers
- ISINUS49177J1025
- FIGIBBG01C79X561
- CUSIP49177J102
- CIK0001944048